• Conference Proceeding

Panitumumab (Pmab) in Combination with Chemotherapy (Ct) Versus Ct Alone: Health-Related Quality of Life (Hrqol) in Patients (Pts) with Wild-Type (Wt) Kras Metastatic Colorectal Cancer (Mcrc)

Citation

Peeters, M., Bennett, L., Zhao, Z. Y., Barber, B., Zhou, X. L., Zhang, J., ... Douillard, J. Y. (2011). Panitumumab (Pmab) in Combination with Chemotherapy (Ct) Versus Ct Alone: Health-Related Quality of Life (Hrqol) in Patients (Pts) with Wild-Type (Wt) Kras Metastatic Colorectal Cancer (Mcrc). In [22], pp. v24–v24. .

Abstract